Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research


Current Drug Targets, Volume 15 - Number 13

Trastuzumab-Induced Cardiotoxicity: Is it a Personalized Risk?

, 15(13): 1200 - 1204

Gerard A. Milano, Emilie Serres, Jean-Marc Ferrero and Joseph Ciccolini

DOI: 10.2174/1389450115666141114151911

Androgen Metabolic Pathway Involved in Current and Emerging Treatment for Men with Castration Resistant Prostate Cancer: Intraprostatic Androgens as Therapeutic Targets and Endocrinological Biomarkers

, 15(13): 1215 - 1224

Noboru Hara and Tsutomu Nishiyama

DOI: 10.2174/1389450115666141024114736

Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients

, 15(13): 1225 - 1230

Riccardo Giampieri, Giuseppe Aprile, Michela Del Prete, Luca Faloppi, Maristella Bianconi, Marta Bonotto, Giampiero Fasola, Stefano Cascinu and Mario Scartozzi

DOI: 10.2174/1389450115666141109212801

Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases

, 15(13): 1231 - 1246

Albino Carrizzo, Maurizio Forte, Maria Lembo, Luigi Formisano, Annibale A. Puca and Carmine Vecchione

DOI: 10.2174/1389450115666141027110156

Evaluation of Non-Coding RNAs as Potential Targets in Head and Neck Squamous Cell Carcinoma Cancer Stem Cells

, 15(13): 1247 - 1260

Elham Rahimy, Selena Z. Kuo and Weg M. Ongkeko

DOI: 10.2174/1389450115666141024113446


Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63


How to write and publish your papers in high impact journalsCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog